2019 (n = 314) * | 2020 (n = 117) | 2021 (n = 201) | 2022 (n = 238) | Total (n = 870) | P value | |
---|---|---|---|---|---|---|
Sex | 0.586 | |||||
Female | 137 (43.6%) | 45 (38.5%) | 81 (40.3%) | 107 (45.0%) | 370 (42.5%) | |
Male | 177 (56.4%) | 72 (61.5%) | 120 (59.7%) | 131 (55.0%) | 500 (57.5%) | |
Median age in months (Interquartile range) | 14.0 (8.0–25.0) | 13.7 (8.1–27.0) | 13.0 (7.5–23.4) | 13.2 (8.5–21.3) | 13.7 (8.1–23.0) | |
Age strata (months) | 0.252 | |||||
<12 | 128 (40.8%) | 51 (43.6%) | 89 (44.3%) | 103 (43.3%) | 371 (42.6%) | |
12–23 | 102 (32.5%) | 36 (30.8%) | 64 (31.8%) | 86 (36.1%) | 288 (33.1%) | |
24–59 | 56 (17.8%) | 13 (11.1%) | 33 (16.4%) | 35 (14.7%) | 137 (15.7%) | |
>60 | 28 (8.9%) | 17 (14.5%) | 15 (7.5%) | 14 (5.9%) | 74 (8.5%) | |
Outcome | < 0.001 | |||||
Alive | 276 (87.9%) | 109 (93.2%) | 183 (91.0%) | 231 (97.1%) | 799 (91.8%) | |
Dead | 10 (3.2%) | 8 (6.8%) | 18 (9.0%) | 5 (2.1%) | 41 (4.7%) | |
Data missing | 28 (8.9%) | 0 (0.0%) | 0 (0.0%) | 2 (0.8%) | 30 (3.4%) | |
Disease severity | 0.01 | |||||
Moderate | 90 (28.7%) | 47 (40.2%) | 45 (22.4%) | 65 (27.3%) | 247 (28.4%) | |
Severe | 224 (71.3%) | 70 (59.8%) | 156 (77.6%) | 173 (72.7%) | 623 (71.6%) |